00954.HK
Changmao Biochemical Engineering Company Limited
HKSE · Basic Materials · Chemicals · CN
HKD 0.23
+0.89%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 556.9M | 584.8M | 637.1M | 730.0M |
| Cost of Revenue | 1.1B | 528.4M | 568.0M | 611.3M | 549.2M |
| Gross Profit | 45.3M | 28.6M | 16.8M | 25.8M | 180.8M |
| Operating Expenses | |||||
| R&D Expense | 17.1M | 6.3M | 10.7M | — | 13.9M |
| SG&A Expense | 156.7M | 75.6M | 81.0M | 83.3M | 97.0M |
| General & Admin Expense | 136.4M | 65.6M | 70.8M | 74.6M | 88.5M |
| Selling & Marketing Expense | 20.2M | 10.1M | 10.2M | 8.7M | 8.4M |
| Other Expenses | (22.9M) | (5.0M) | (17.9M) | (5.5M) | (19.4M) |
| Total Operating Expenses | 150.8M | 76.9M | 73.8M | 77.9M | 91.5M |
| Cost and Expenses | 1.2B | 605.3M | 641.9M | 689.1M | 642.7M |
| Operating Income (EBIT) | (105.4M) | (48.4M) | (57.1M) | (52.0M) | 89.4M |
| Non-Operating | |||||
| Interest Income | 1.6M | 615.6K | 846.0K | 1.1M | 940.0K |
| Interest Expense | 24.4M | 16.8M | 11.4M | 7.6M | 2.7M |
| Net Interest Income | (27.2M) | (16.2M) | (10.5M) | (6.5M) | (1.7M) |
| Other Non-Op Income/Expense | (27.1M) | (16.6M) | (10.5M) | (6.5M) | (1.7M) |
| Non-Operating Income (excl Interest) | (10.6M) | (10.9M) | 320.0K | (1.1M) | (940.0K) |
| EBT (Pre-Tax Income) | (132.5M) | (65.0M) | (67.6M) | (58.6M) | 87.6M |
| Income Tax Expense | 2.9M | 2.2M | 669.0K | 27.9M | 6.3M |
| Bottom Line | |||||
| Net Income | (135.0M) | (66.8M) | (68.2M) | (86.1M) | 81.4M |
| Earnings from Cont. Ops | (135.4M) | (67.2M) | (68.3M) | (86.5M) | 81.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (135.0M) | (66.8M) | (68.2M) | (86.1M) | 81.4M |
| Per Share | |||||
| Basic EPS | (HK$0.25) | (HK$0.13) | (HK$0.13) | (HK$0.16) | HK$0.15 |
| Diluted EPS | (HK$0.25) | (HK$0.13) | (HK$0.13) | (HK$0.16) | HK$0.15 |
| Revenue Per Share | HK$2.16 | HK$1.05 | HK$1.10 | HK$1.20 | HK$1.38 |
| Shares | |||||
| Basic Shares Outstanding | 529.7M | 529.7M | 529.7M | 529.7M | 529.7M |
| Diluted Shares Outstanding | 529.7M | 529.7M | 529.7M | 529.7M | 529.7M |
| Profitability Metrics | |||||
| EBITDA | (4.0M) | 13.8M | (17.7M) | (8.3M) | 122.5M |
| D&A | 90.9M | 51.2M | 39.7M | 42.7M | 32.2M |
| EBIT | (94.8M) | (37.4M) | (57.4M) | (51.0M) | 90.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025